European Journal of Biotechnology and Bioscience

European Journal of Biotechnology and Bioscience


European Journal of Biotechnology and Bioscience
European Journal of Biotechnology and Bioscience
Vol. 9, Issue 2 (2021)

Increasing antimicrobial resistance for uropathogens: Fosfomycin


Krishna Kumar Patel, Sarita Patel, Neetu Harmukh, Akanksha Gupta

Urinary tract infection (UTI) is one of the choice of antibiotics for the treatment of UTI an urgent need to discover new effective treatment solutions. Fosfomycin may be an interesting alternative to the currently used treatments of UTIs. The study was conducted over 6 months per Microbiology, Chhattisgarh Institute of Medical Science, Bilaspur. A total of 1240 done as per standard microbiological procedures. Methicillinresistant Staphylococcus aureus (MRSA), high-aminoglycoside resistance (HLAR), extended spectrum (MBL) production was detected. Culture was positive in 339 (27.4%) cases. Gram production was detected in 154 (37.1%) while 82 (21 bacteria, 68 (51.5%) were MRSA. Fosfomycin was effective to fosfomycin in AmpC producers was extremely high effective as only three isolates were sensitive to cotrimoxazole. Pseudomonas species showed 65% and 75% susceptiblee. Fosfomycin has emerged as a promising option, pathogens in which previous antibiotics have failed to cure the infection.
Download  |  Pages : 18-21
How to cite this article:
Krishna Kumar Patel, Sarita Patel, Neetu Harmukh, Akanksha Gupta. Increasing antimicrobial resistance for uropathogens: Fosfomycin. European Journal of Biotechnology and Bioscience, Volume 9, Issue 2, 2021, Pages 18-21
European Journal of Biotechnology and Bioscience